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A b s t r a c t
Background: Ischaemic episodes preceding myocardial infarction (MI) are one of the defence mechanisms protecting the
body from the consequences of sudden ischaemia. Left ventricular free wall rupture (LVFWR) is a rare complication of MI but
leading, in a majority of patients, to sudden cardiac death.
Aim: To assess the impact of a previous history of ischaemic episodes (IEs) on the occurrence of LVFWR in patients with acute
MI (AMI) managed by percutaneous coronary intervention (PCI).
Methods: The study population consisted of 270 patients who had died during hospitalisation for AMI. All the patients were
managed by PCI. The study group (the LVFWR group) consisted of 49 patients who developed LVFWR during hospitalisation
and the control group (the non-LVFWR group) consisted of the remaining 221 patients who had died from causes other than
LVFWR. In all the patients with LVFWR the rupture was confirmed by autopsy. The data on AMI was obtained from history or
medical records. The data on IEs was obtained on the basis of the symptoms that were reported by the patients in the past
that directly preceded the most recent AMI or on the basis of medical records.
Results: Compared to the non-LVFWR group the LVFWR group was characterised by an older age (70.3 ± 3.4 vs. 65.2 ± 9.9
years, p < 0.001) and a higher percentage of females (75.0% vs. 60.2%, p < 0.001). The LVFWR group was also character-
ised by a higher percentage of IEs in the past (61.2% vs. 40.2%, p = 0.003), a lower percentage of patients with a history of
MI (14.2% vs. 33.4%, p = 0.004), a higher percentage of patients with multivessel coronary artery disease (77.5% vs. 61.5%,
p = 0.03), a longer interval from the onset of symptoms to PCI (9.0 ± 5.5 vs. 4.5 ± 3.2 h, p < 0.001) and a lower percentage
of patients with IEs in the past but without an MI (6.1% vs. 23.9%, p < 0.001). Our study showed that independent risk factors
for LVFWR in the setting of AMI were: older age (OR 1.1, 95% CI 1.02–1.19), male sex (OR 0.2, 95% CI 0.07–0.52) and
a longer interval between the onset of symptoms and PCI (OR 1.25, 95% CI 1.07–1.47).
Conclusions: A previous history of IEs in patients without a previous history of AMI was a protective factor against the
development of LVFWR in the setting of AMI.
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INTRODUCTION
A history of ischaemic episodes (IEs) are one of the protective
mechanisms currently recognised as one of the protective
mechanism of the heart against the consequences of ischa-
emia. This is an adaptive protective mechanism in the myo-
cardium during its ischaemia whereby brief IEs increase my-
ocardial tolerability of subsequent, longer episodes of ischa-
emia, making the myocardium impervious to subsequent
more extensive injury [1–3].
There has recently been a gradual increase in the num-
ber of percutaneous coronary interventions (PCI), including
PCI as a management option in acute myocardial infarction
(AMI). This has resulted in a considerable improvement of
both in-hospital and long-term outcomes in patients with MI
[4–7]. There are still, however, potentially fatal complications
whose development is difficult to predict and which are diffi-
cult to manage. One such complication is left ventricular free
wall rupture (LVFWR). LVFWR is a rare complication of MI
which in most cases leads to sudden cardial death.
The aim of our study was to assess the impact of a pre-
vious history of IEs on the occurrence of LVFWR in patients
with AMI managed by PCI.
METHODS
Over a period of 4 years a total of 4200 consecutive pa-
tients with AMI underwent PCI at the Silesian Centre for
Heart Diseases. The study population consisted of 270 pa-
tients who had died during hospitalisation for AMI. All the
patients were managed with PCI. Sixty-two (22.9%) of pa-
tients with LVFWR also received thrombolytic treatment
prior to PCI and 72 (26.6%) patients received glycoprotein
IIb/IIIa inhibitors.
The study population was divided in a group of 49 pa-
tients who had died during hospitalisation for LVFWR (the
LVFWR group) and the control group of 221 patients who
had died from causes other than LVFWR.
The LVFWR in all the patients who died from this cause
during hospitalisation was confirmed by autopsy. None of the
patients underwent surgery. The data on the previous history
of MI was obtained from the history or medical records. The
data on the previous history of IEs was obtained on the basis
of the symptoms that were reported by the patients in the
past that directly preceded the most recent AMI or on the
basis of medical records. The duration of each IE ranged from
2 to 15 min.
Statistical analysis
The values calculated for measureable variables were expres-
sed as arithmetic means and standard deviations. For data
with normal distribution the comparative analysis was perfor-
med using the t-Student test. The distributions of the risk fac-
tors between the groups were compared using the c2 test.
A multivariate logistic regression model was used to calculate
the relationship between the set of independent variables (in-
dependent risk factors) and dependent variable (LVFWR).
RESULTS
The LVFWR occurred in 18.1% of the patients who died from
AMI. The demographic data and co-morbidities in the study
population are summarised in Table 1. Older age and female
sex were significantly more often observed in patients with
LVFWR. Table 2 summarises the results on the history of co-
ronary artery disease (CAD), location of the MI and treatment
in the study population. A previous history of IEs, no previous
history of MI, multivessel CAD and a longer interval between
the onset of symptoms to PCI were significantly more com-
mon in the LVFWR group. From all the obtained qualitative
risk factors for LVFWR that were significantly more common
in the LVFWR group, independent risk factors for LVFWR
were identified using multivariate logistic regression analysis.
The development of LVFWR was the dependent variable and
factors that were significantly more common in the LVFWR
group than in the control group. Table 3 summarises the re-
sults of the multivariate analysis.
We showed that independent risk factors for LVFWR in
the setting of AMI were: older age (OR 1.1, 95% CI 1.02–
–1.19, p = 0.01), male sex (OR 0.2, 95% CI 0.07–0.52,
p = 0.001) and a longer interval between the onset of symp-
toms and PCI (OR 1.25, 95% CI 1.07–1.47, p = 0.003).
A previous history of IEs in patients without a previous
history of AMI was a protective factor against the develop-
ment of LVFWR, which suggests that the absence of the abo-
ve is an independent risk factor for LVFWR (OR 0.09, 95% CI
0.09–4.10, p = 0.01).
Table 1. Demographic data and co-morbidities
LVFWR group (n = 49) Non-LVFWR group (n = 221) P
Age [years] 70.3 ± 3.2 65.2 ± 9.9 < 0.001*
Sex 37 (75%) females and 2 (25%) males 88 (60.2%) females and 133 (39.8%) males < 0.001**
Hypertension 20 (40.8%) patients 121 (54.7%) patients NS**
Diabetes mellitus 15 (30.6%) patients 71 (32.1%) patients NS**
*t-Student test; **c2; LVFWR — left ventricular free wall rupture
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DISCUSSION
The LVFWR is always a serious complication of AMI. Despite
the advent of PCI the incidence of LVFWR in AMI patients
continues to be significantly high [8–11]. The LVFWR com-
plicating AMI is nearly always fata. with most of the ruptures
being discovered during postmortem. The prevalence of
LVFWR is estimated at several to less than 20% of all deaths
caused by AMI [8, 9, 12, 13]. A previous history of IEs in
patients with AMI is associated with milder left ventricular
injury [14, 15], less frequent occurrence of LVFWR in ante-
rior wall MI [14], less frequent occurrence of heart failure and
death due to AMI [16] and of ventricular fibrillation [17].
Preconditioning is a protective mechanism of the myo-
cardium during its ischaemia that increases myocardial to-
lerability of subsequent episode of ischaemia. The exact pa-
thomechanism of preconditioning is unclear, although a si-
gnificant role may be played by the activation of ATP-de-
pendent potassium channels [1, 18]. Decreased intracellular
ATP levels result in the opening of potassium channels,
whose activation leads to cell membrane hyperpolarisation,
shortening of the action potential and reduced calcium in-
flux into the cells. This decreases ATP consumption and re-
duces myocardial contractility, which spares the myocar-
dial energy reserves.
The decreased calcium influx into the cells also results in
vasodilation in the specific area of the myocardium. The ef-
fectors of preconditioning are ATP-sensitive potassium chan-
nels, closed by ATP [1, 18, 19]. Animal experimental studies
have shown that the late phase of preconditioning does not
exceed 70 h. However, certain clinical studies have demon-
strated that the duration of the protective effect of IEs may be
much longer and be maintained for up to 90 days [20]. Our
study showed that patients who developed LVFWR had si-
gnificantly less commonly experienced IEs than patients who
died from causes other than LVFWR. This is related to the
previous history of IEs, which make the myocardium “immu-
ne” to sudden ischaemia, such as the acute ischaemia cau-
sed by MI.
When we analysed a subgroup of patients with a previous
history of IEs but without a previous history of IEs we found
a lower rate of LVFWR. In addition, patients with LVFWR had
a significantly lower rate of a previous history of MI. Several
publications have also shown a higher risk of LVFWR in pa-
tients without a previous history of MI [11, 21]. It has been
Table 2. Results regarding the history of coronary artery disease and the location and treatment of acute myocardial infarction
LVFWR group Non-LVFWR group P
Previous history of IEs* 30 (61.2%) 89 (40.2%) 0.003**
Previous history of MI 7 (14.2%) 74 (33.4%) 0.004**
Previous history of IEs but no previous history of MI 4 (6.1%) 53 (23.9%) < 0.001
History of more than one MI 1 (2.0%) 19 (8.5%) 0.05
Most recent acute MI: anterior wall infraction 30 (61.2%) 129 (58,3%) NS**
Multivessel coronary artery disease 38 (77.5%) 136 (61.5%) 0.03
Time from onset of symptoms to PCI [h] 9.0 ± 5.5 4.5 ± 3.2 < 0.001
Thrombolytic treatment 12 (24.4%) 50 (22.6%) NS**
Glycoprotein IIb/IIIa inhibitor 10 (20.4%) 62 (28.0%) NS**
*IEs in patients with LVFWR inclusive (with or without a history of MI); **c2 test; LVFWR — left ventricular free wall rupture; IEs — ischaemic episodes;
MI — myocardial infarction; PCI — percutaneous coronary intervention
Table 3. Multivariate analysis results
P Odds ratio 95% CI lower limit 95% CI upper limit
Age [years] 0.01 1.1 1.02 1.19
Sex — males/females 0.001 0.2 0.07 0.52
Time to PCI [h] 0.003 1.25 1.07 1.47
Previous history of MI 0.84 0.89 0.27 2.86
Previous history of IEs* 0.07 2.39 0.92 6.22
Multivessel coronary artery disease 0.13 2.05 0.8 5.25
Previous history of IEs but not of MI 0.01 0.2 0.06 0.69
*IEs in patients with LVFWR inclusive (with or without a history of MI); CI — confidence interval; LVFWR — left ventricular free wall rupture;
IEs — ischaemic episodes; MI — myocardial infarction; PCI — percutaneous coronary intervention
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hypothesised that the scar and the collateral circulation that
develop during the previous MI exert protective effects against
the development of LVFWR during the subsequent MI [11].
On the other hand, despite the less frequent occurrence
of LVFWR in patients with a previous history of CAD our
multivariate analysis showed that the previous history of MI
was not an independent risk factor of LVFWR.
A study by Becker et al. [21] showed that a previous hi-
story of MI was an independent risk factor of death from cau-
ses other than LVFWR, but the participants of the study did
not receive invasive treatment. In the same study, a previous
history of IEs unrelated to a previous history of MI was asso-
ciated with a higher incidence of LVFWR [21]. In the SHOCK
registry, a history of MI was an independent factor that de-
creased the risk of LVFWR [11]. Also the authors of the re-
cently published Global Registry of Acute Coronary Events
(GRACE) study with a subgroup of 273 patients with LVFWR
showed that a history of MI was an independent protective
factor against the occurrence of LVFWR [13]. GRACE was
conducted in patients with ST-elevation MI (STEMI), non-
STEMI and unstable angina. In addition, in the GRACE regi-
stry, STEMI was an independent risk factor of LVFWR [13]. It
should also be noted that the populations assessed for the
impact of a previous history of MI on the development of
LVFWR differed between each other in terms of the clinical
course and treatment [11, 13, 21].
Having considered the studies published so far, we ana-
lysed an additional subgroup of patients with a previous hi-
story of IEs but without a previous history of MI and found
that this was an independent risk factor of LVFWR. We conc-
luded that a previous history of IEs without a previous history
of MI is a better protection against LVFWR during AMI than
a previous history of both IEs and MI. In the era of invasive
treatment our data allow us to confirm the fact that myocar-
dial preconditioning through repeated episodes of ischaemia
is an important mechanism that provides protection against
LVFWR in patients with AMI.
We also found that the presence of a post-MI scar we-
akens the beneficial effect of a previous history of IE prece-
ding AMI.
It has been hypothesised that the differences in stresses
between the scar and the myocardium not affected by ne-
crosis and the related abnormalities of contractility may im-
pair the function of ATP-dependent potassium channels.
CONCLUSIONS
A previous history of IEs and a previous history of MI are si-
gnificantly less common in patients with LVFWR in the set-
ting of AMI managed with PCI.
No previous history of IEs in patients without a history of
MI, older age, female sex and a longer interval from the onset
of symptoms to PCI are independent risk factors of LVFWR
as a serious complication of MI.
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S t r e s z c z e n i e
Wstęp: Epizody niedokrwienne poprzedzające zawał serca (MI) stanowią jeden z mechanizmów obronnych przed skutkami
nagłego niedokrwienia. Pęknięcie wolnej ściany lewej komory (CR) jest rzadkim powikłaniem MI, prowadzącym w większo-
ści przypadków do nagłego zgonu sercowego.
Cel: Celem pracy była ocena wpływu przebytych epizodów niedokrwiennych (IE) na wystąpienie CR u chorych z ostrym MI
(AMI) leczonych metodą przezskórnej interwencji wieńcowej (PCI).
Metody: Badaniem objęto populację 270 pacjentów, u których w okresie wewnątrzszpitalnym wystąpił zgon w przebiegu
AMI; wszyscy chorzy byli poddani PCI. Grupa badana (grupa CR) składała się z 49 osób, u których w okresie wewnątrzszpital-
nym wystąpiło CR, a grupę kontrolną (grupa non-CR) stanowiło 221 chorych, u których zgon wystąpił z innego powodu niż CR.
U wszystkich pacjentów CR potwierdzono sekcyjnie. Dane dotyczące przebytego MI uzyskano z wywiadu bądź na podstawie
dokumentacji medycznej, a informacje na temat IE na podstawie obecności dolegliwości zgłaszanych przez chorego w prze-
szłości lub poprzedzających bezpośrednio wystąpienie obecnego AMI lub na podstawie dokumentacji medycznej.
Wyniki: Chorzy, u których doszło do CR, byli starsi (70,3 ± 3,2 v. 65,2 ± 9,9 roku; p < 0,001), częściej CR dotyczyło kobiet
(w grupie CR kobiety stanowiły 75%, a w grupie non-CR 60,2%; p < 0,001). W grupie chorych z CR częściej obserwowano
przebyte IE (61,2% v. 40,2%; p = 0,003), rzadziej przebyty MI (14,2% v. 33,4%; p = 0,004), częściej wielonaczyniową
chorobę wieńcową (77,5% v. 61,5%; p = 0,03), dłuższy czas od początku objawów do PCI (9,0 ± 5,5 v. 4,5 ± 3,2 h;
p < 0,001) oraz rzadziej przebyte IE bez przebytego MI (6,1% v. 23,9%; p < 0,001). Niezależnymi czynnikami ryzyka
wystąpienia CR w przebiegu AMI był starszy wiek (OR 1,1; 95% Cl 1,02–1,19), płeć żeńska (OR 0,2 dla płci męskiej; 95% Cl
0,07–0,52) i dłuższy czas od wystąpienia objawów do PCI (OR 1,25; 95% Cl 1,07–1,47).
Wnioski: Obecność uprzednich IE u chorych bez przebytego MI stanowiła czynnik ochronny przed wystąpieniem CR w prze-
biegu AMI.
Słowa kluczowe: pęknięcie lewej komory, przebyte niedokrwienie, zawał serca
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